Janus Henderson Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-28,759
Closed -$202K – 2459
2022
Q3
$202K Sell
28,759
-18,609
-39% -$129K ﹤0.01% 1871
2022
Q2
$395K Sell
47,368
-126,507
-73% -$1.77M ﹤0.01% 1909
2022
Q1
$3.98M Sell
173,875
-262,796
-60% -$6.42M ﹤0.01% 1060
2021
Q4
$12.1M Buy
436,671
+370,230
+557% +$9.91M 0.01% 886
2021
Q3
$1.86M Sell
66,441
-6,347
-9% -$180K ﹤0.01% 1265
2021
Q2
$2.14M Sell
72,788
-13,859
-16% -$420K ﹤0.01% 1222
2021
Q1
$2.74M Sell
86,647
-25,807
-23% -$757K ﹤0.01% 1130
2020
Q4
$2.33M Sell
112,454
-49,520
-31% -$924K ﹤0.01% 1097
2020
Q3
$2.51M Buy
161,974
+19,479
+14% +$336K ﹤0.01% 1022
2020
Q2
$2.6M Buy
142,495
+1,027
+0.7% +$18.1K ﹤0.01% 996
2020
Q1
$2.17M Sell
141,468
-127,403
-47% -$3.07M ﹤0.01% 995
2019
Q4
$8.06M Buy
268,871
+1,600
+0.6% +$41.6K ﹤0.01% 979
2019
Q3
$5.83M Sell
267,271
-72,400
-21% -$1.66M ﹤0.01% 1034
2019
Q2
$8.58M Sell
339,671
-831,800
-71% -$19.7M ﹤0.01% 969
2019
Q1
$28.9M Buy
1,171,471
+292,076
+33% +$6.98M 0.02% 705
2018
Q4
$16.3M Buy
879,395
+376,500
+75% +$8.96M 0.01% 800
2018
Q3
$12.9M Buy
+502,895
New +$11.5M 0.01% 890
2018
Q2
– Sell
-136,116
Closed -$2.17M – 1396
2018
Q1
$2.17M Buy
+136,116
New +$2.53M ﹤0.01% 1154
2015
Q3
– Sell
-35,641
Closed -$7.92M – 836
2015
Q2
$7.92M Hold
35,641
– – 0.06% 294
2015
Q1
$7.09M Buy
+35,641
New +$6.32M 0.05% 324
2013
Q3
– Sell
-75,000
Closed -$6.6M – 755
2013
Q2
$6.6M Buy
+75,000
New +$5.91M 0.08% 232

Other funds holding BHC

Janus Henderson Group's BHC Position: Q4 2022 in Review

Janus Henderson Group sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 28,759 shares — an estimated $202K sold.

Janus Henderson Group first reported a position in BHC in Q2 2013 and held it in 21 quarters. The position peaked at $28.9M in Q1 2019. 260 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Janus Henderson Group reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Janus Henderson Group sold 28,759 Bausch Health shares in Q4 2022, an estimated $202K.
  • Janus Henderson Group first reported a position in Bausch Health in Q2 2013 and held it in 21 quarters.
  • Janus Henderson Group's Bausch Health position peaked at $28.9M in Q1 2019.
  • 260 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.